Tredje AP fonden Sells 1,057 Shares of UiPath Inc. (NYSE:PATH)

Tredje AP fonden lowered its position in UiPath Inc. (NYSE:PATH) by 1.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,458 shares of the healthcare company’s stock after selling 1,057 shares during the quarter. Tredje AP fonden’s holdings in UiPath were worth $843,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. ORG Partners LLC raised its position in UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after purchasing an additional 1,112 shares during the period. Hantz Financial Services Inc. bought a new position in shares of UiPath during the second quarter valued at about $28,000. Redwood Wealth Management Group LLC purchased a new position in shares of UiPath in the second quarter worth about $43,000. Lindbrook Capital LLC lifted its stake in shares of UiPath by 46.0% in the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock valued at $46,000 after acquiring an additional 639 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock valued at $50,000 after acquiring an additional 632 shares during the period. 62.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UiPath

In other news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the transaction, the chief financial officer now owns 849,917 shares in the company, valued at approximately $10,258,498.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 22.37% of the company’s stock.

UiPath Stock Up 0.3 %

Shares of PATH stock opened at $12.49 on Friday. The company has a 50 day moving average price of $12.13 and a 200-day moving average price of $16.01. UiPath Inc. has a 52 week low of $10.37 and a 52 week high of $27.87. The firm has a market capitalization of $7.15 billion, a PE ratio of -78.06 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The firm had revenue of $316.00 million for the quarter, compared to analysts’ expectations of $303.69 million. During the same period in the prior year, the firm earned ($0.09) EPS. The company’s revenue was up 10.0% compared to the same quarter last year. Analysts anticipate that UiPath Inc. will post -0.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PATH has been the subject of several recent research reports. Macquarie downgraded UiPath from an “outperform” rating to a “neutral” rating and lowered their price objective for the company from $29.00 to $12.00 in a research report on Monday, June 3rd. DA Davidson increased their price target on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Needham & Company LLC restated a “hold” rating on shares of UiPath in a research report on Friday, September 6th. Wells Fargo & Company increased their target price on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a report on Friday, September 6th. Finally, Canaccord Genuity Group reduced their price target on UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a report on Friday, May 31st. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, UiPath has an average rating of “Hold” and a consensus target price of $17.71.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.